BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1198 related articles for article (PubMed ID: 27908847)

  • 1. Homeostasis of the gut barrier and potential biomarkers.
    Wells JM; Brummer RJ; Derrien M; MacDonald TT; Troost F; Cani PD; Theodorou V; Dekker J; Méheust A; de Vos WM; Mercenier A; Nauta A; Garcia-Rodenas CL
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G171-G193. PubMed ID: 27908847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
    Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and its pathophysiology in disease paradigms.
    Festi D; Schiumerini R; Birtolo C; Marzi L; Montrone L; Scaioli E; Di Biase AR; Colecchia A
    Dig Dis; 2011; 29(6):518-24. PubMed ID: 22179206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the Gastrointestinal Microbiota in Visceral Pain.
    Rea K; O'Mahony SM; Dinan TG; Cryan JF
    Handb Exp Pharmacol; 2017; 239():269-287. PubMed ID: 28035535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus clausii and gut homeostasis: state of the art and future perspectives.
    Lopetuso LR; Scaldaferri F; Franceschi F; Gasbarrini A
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):943-8. PubMed ID: 27291780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, enteroendocrine functions and metabolism.
    Cani PD; Everard A; Duparc T
    Curr Opin Pharmacol; 2013 Dec; 13(6):935-40. PubMed ID: 24075718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes.
    Clark A; Mach N
    J Int Soc Sports Nutr; 2016; 13():43. PubMed ID: 27924137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal epithelial barrier functions in ageing.
    Branca JJV; Gulisano M; Nicoletti C
    Ageing Res Rev; 2019 Sep; 54():100938. PubMed ID: 31369869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiota-gut-brain axis in functional gastrointestinal disorders.
    De Palma G; Collins SM; Bercik P
    Gut Microbes; 2014; 5(3):419-29. PubMed ID: 24921926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advance and future of research on gut homeostasis and related diseases].
    Liu XW; Sun RJ; Ding ED
    Sheng Li Ke Xue Jin Zhan; 2013 Jun; 44(3):206-12. PubMed ID: 24027828
    [No Abstract]   [Full Text] [Related]  

  • 14. The gut microbiome and the brain.
    Galland L
    J Med Food; 2014 Dec; 17(12):1261-72. PubMed ID: 25402818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
    Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
    Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut barrier in health and disease: focus on childhood.
    Viggiano D; Ianiro G; Vanella G; Bibbò S; Bruno G; Simeone G; Mele G
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1077-85. PubMed ID: 25855935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRPs, microbiota, and gut homeostasis: unravelling the connection.
    Zambetti LP; Mortellaro A
    J Pathol; 2014 Aug; 233(4):321-30. PubMed ID: 24740681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.
    Natividad JM; Verdu EF
    Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Immune System Interactions.
    Yoo JY; Groer M; Dutra SVO; Sarkar A; McSkimming DI
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33076307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
    Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.